Sermorelin BAC Water & Reconstitution Guide
Sermorelin is a synthetic growth hormone-releasing hormone fragment that has been studied for stimulating endogenous growth hormone secretion. Historical human research includes diagnostic studies and pediatric growth-hormone-deficiency research; the concentration examples on this page are mathematical research calculations and are not treatment or dosing recommendations.
How Much BAC Water for Sermorelin?
There is no single universal BAC-water volume that produces one required sermorelin concentration. The liquid volume selected determines the resulting concentration. The amount of sermorelin represented by the vial does not change when the amount of liquid changes.
Illustrative Sermorelin Concentration Examples
Concentration = total vial quantity ÷ liquid volume. Values are calculated in mg/mL.
| Illustrative vial quantity | 1 mL | 2 mL | 2.5 mL | 3 mL | 5 mL |
|---|---|---|---|---|---|
| 1 mg | 1 mg/mL | 0.5 mg/mL | 0.4 mg/mL | 0.33 mg/mL | 0.2 mg/mL |
| 5 mg | 5 mg/mL | 2.5 mg/mL | 2 mg/mL | 1.67 mg/mL | 1 mg/mL |
| 10 mg | 10 mg/mL | 5 mg/mL | 4 mg/mL | 3.33 mg/mL | 2 mg/mL |
Need a different vial quantity or BAC-water volume?
Use the BacScience Universal BAC Water Calculator to calculate concentration from a custom vial quantity and liquid volume.
How Much BAC Water Should Be Added to a Sermorelin Vial?
The mathematically correct answer depends on the amount of sermorelin in the vial and the concentration being targeted. There is therefore no scientifically universal statement such as “sermorelin always requires X mL of BAC water.”
For example, if a hypothetical vial contains 5 mg of sermorelin, adding 1 mL of liquid results in 5 mg/mL, while adding 2 mL results in 2.5 mg/mL. The total quantity remains 5 mg; only the concentration changes.
How Much BAC Water for Sermorelin 5 mg?
For a hypothetical 5 mg vial, the mathematical relationship is: 5 mg ÷ liquid volume. Therefore, 1 mL produces 5 mg/mL, 2 mL produces 2.5 mg/mL, 2.5 mL produces 2 mg/mL, and 5 mL produces 1 mg/mL.
How Much BAC Water for Sermorelin 10 mg?
For a hypothetical 10 mg vial, 1 mL corresponds to 10 mg/mL, 2 mL corresponds to 5 mg/mL, 2.5 mL corresponds to 4 mg/mL, 3 mL corresponds to approximately 3.33 mg/mL, and 5 mL corresponds to 2 mg/mL.
How Does BAC-Water Volume Change Sermorelin Concentration?
Increasing the liquid volume decreases concentration because the same quantity of compound is distributed through a larger volume. Decreasing the liquid volume increases concentration.
How Do You Calculate Sermorelin Concentration?
The fundamental concentration calculation is simple and can be applied to any accurately known vial quantity and liquid volume.
What Is Sermorelin?
Sermorelin is a synthetic peptide corresponding to the N-terminal 29 amino acids of growth hormone-releasing hormone (GHRH). It acts through the GHRH pathway and can stimulate growth hormone secretion from the anterior pituitary when functional pituitary tissue is present.
Human research has evaluated sermorelin and related GHRH fragments in growth-hormone stimulation, diagnostic testing, and pediatric growth disorders. A published review describes intravenous and subcutaneous sermorelin as stimulators of growth hormone secretion and summarizes historical clinical research.
How Does Sermorelin Work?
Sermorelin functions as a growth hormone-releasing hormone analog. The biological concept is stimulation of the pituitary somatotroph system, which can increase endogenous growth hormone secretion.
GHRH pathway
Sermorelin is structurally related to the biologically active N-terminal portion of GHRH.
Pituitary signaling
GHRH-pathway signaling can stimulate pituitary growth hormone release when the relevant pituitary function is preserved.
GH response
Human studies have measured changes in circulating growth hormone following administration of GHRH or sermorelin.
What Is Sermorelin Being Studied For?
Historical human research has investigated sermorelin primarily in relation to growth hormone secretion, growth hormone deficiency, growth assessment, and diagnostic stimulation testing.
Growth hormone deficiency
Sermorelin was investigated in children with growth hormone deficiency and growth failure.
GH stimulation testing
Human studies examined sermorelin/GHRH responses as part of investigations of pituitary growth hormone secretion.
Growth hormone physiology
Research has examined dose-response relationships and the effects of GHRH stimulation on circulating growth hormone.
Human Clinical Research
Sermorelin has been studied in humans for several decades. The historical literature includes controlled physiological studies, diagnostic investigations, and treatment research in children with growth hormone deficiency.
One multicenter study evaluated 110 previously untreated, prepubertal children with growth hormone deficiency who received 30 micrograms/kg/day of GHRH-(1-29) subcutaneously at bedtime. The study reported increased height velocity during the first year of treatment. This is a published research regimen and is not a BacScience recommendation. :contentReference[oaicite:2]{index=2}
A separate dose-response study investigated 1, 10, and 100 microgram doses of GHRH(1-29)NH2 in humans and observed different growth-hormone responses across the dose range. Again, those quantities belong to a specific experimental study design and should not be converted into generalized treatment instructions. :contentReference[oaicite:3]{index=3}
Doses Studied in Published Research
The table below summarizes examples from published human literature. These are historical research doses and experimental conditions, not BacScience dosage recommendations.
| Study | Population | Dose studied | Route | Frequency | Research context |
|---|---|---|---|---|---|
| Geref International Study Group | Prepubertal children with GH deficiency | 30 µg/kg/day | Subcutaneous | Once daily | Growth hormone deficiency / growth research |
| Low-dose GHRH dose-response study | Human volunteers | 1–100 µg experimental doses | Intravenous | Single experimental administration | Growth hormone stimulation / dose response |
| Sermorelin diagnostic research | Children / endocrine evaluation | Study-specific | Intravenous or subcutaneous | Study-specific | GH stimulation and diagnostic investigation |
Preclinical Research
Sermorelin research is primarily notable for its endocrine and human clinical literature rather than being a compound whose evidence base depends exclusively on animal models. Preclinical and mechanistic studies of GHRH signaling nevertheless contribute to understanding how GHRH-derived peptides interact with the growth-hormone axis.
Preclinical findings should not be treated as evidence of clinical effectiveness. Results from animals or laboratory systems can establish biological hypotheses but cannot independently establish an appropriate human dose, efficacy, or safety profile.
Research Reconstitution & Concentration
For concentration mathematics, the essential variables are the total quantity of compound and the liquid volume. The resulting concentration is calculated using:
Worked Example: 5 mg Sermorelin
Suppose a hypothetical vial contains 5 mg and the selected liquid volume is 2 mL:
Worked Example: 10 mg Sermorelin
For a hypothetical 10 mg quantity:
BAC Water vs. Sermorelin Concentration
The volume of liquid and the amount of compound are different variables. Increasing the liquid volume distributes the same quantity across more milliliters, producing a lower concentration.
5 mg remains 5 mg
Adding more liquid does not create more sermorelin.
Lower concentration
A larger volume produces fewer milligrams per milliliter.
Higher concentration
A smaller volume produces more milligrams per milliliter.
Calculate your own concentration
Enter the actual vial quantity and selected liquid volume.
Research Limitations & Safety
FDA Regulatory History
FDA records identify sermorelin acetate under the trade name Geref and document a marketing approval dated September 26, 1997 for the pediatric indication associated with idiopathic or organic growth hormone deficiency and growth failure. :contentReference[oaicite:4]{index=4}
FDA's historical regulatory record should be distinguished from modern compounded products, research materials, off-label use, or claims made by online sellers. Regulatory status can also differ by jurisdiction and product formulation.
Clinical Dose vs. Research Dose
A clinical dose is an authorized or medically determined treatment quantity. A research dose is the quantity used under the conditions of a particular study. A community protocol is neither automatically a clinical dose nor evidence of efficacy.
These categories should never be treated as interchangeable.
Frequently Asked Questions About Sermorelin BAC Water & Reconstitution
How much BAC water should be used for sermorelin?
There is no universal volume that applies to every sermorelin vial. The appropriate volume depends on the specific product, vial quantity, intended concentration, and applicable instructions. Mathematically, concentration equals vial quantity divided by liquid volume.
How much BAC water for 5 mg sermorelin?
A 5 mg quantity produces 5 mg/mL with 1 mL, 2.5 mg/mL with 2 mL, 2 mg/mL with 2.5 mL, and 1 mg/mL with 5 mL. These are mathematical examples rather than recommended reconstitution instructions.
How much BAC water for 10 mg sermorelin?
A hypothetical 10 mg quantity corresponds to 10 mg/mL in 1 mL, 5 mg/mL in 2 mL, 4 mg/mL in 2.5 mL, 3.33 mg/mL in 3 mL, and 2 mg/mL in 5 mL.
What is the sermorelin reconstitution formula?
The basic concentration formula is: concentration in mg/mL = total compound quantity in mg divided by liquid volume in mL.
Does adding more BAC water change the amount of sermorelin?
No. Adding liquid changes the concentration, not the total quantity of compound represented by the vial.
Does more BAC water make sermorelin weaker?
It produces a lower concentration because the same quantity is distributed through a larger volume. It does not remove compound from the vial or change the stated total quantity.
What concentration is 5 mg sermorelin in 2 mL?
5 mg divided by 2 mL equals 2.5 mg/mL.
What concentration is 10 mg sermorelin in 2 mL?
10 mg divided by 2 mL equals 5 mg/mL.
Is sermorelin FDA approved?
FDA records document historical marketing approval of sermorelin acetate under Geref for a pediatric growth-hormone-deficiency indication. That historical approval should not be interpreted as blanket approval for every current formulation, purpose, or use.
Is sermorelin the same as growth hormone?
No. Sermorelin is a GHRH-derived peptide that can stimulate endogenous growth hormone secretion. Recombinant growth hormone, such as somatropin, is a different biological product.
Are published sermorelin doses recommendations?
No. Published doses describe the protocols used in particular research studies. They should not be converted into individualized treatment recommendations.
Where can I calculate a different sermorelin concentration?
The BacScience Universal BAC Water Calculator allows users to enter custom vial quantities and liquid volumes to calculate mathematical concentration.
Related BacScience Research Resources
BAC Water Calculator
Calculate concentration using a custom vial quantity and liquid volume.
Open BAC Water Calculator →Research Compound Library
Explore compound-specific scientific information, concentration mathematics, and research references.
Explore Research Library →Testing & Transparency
Review BacScience resources covering analytical testing, documentation, and research transparency.
Testing & Transparency →Scientific References
- U.S. Food and Drug Administration — Orphan Drug Designations and Approvals. Sermorelin acetate / Geref. Historical FDA marketing approval information. FDA record.
- Geref International Study Group. Once daily subcutaneous growth hormone-releasing hormone therapy accelerates growth in growth hormone-deficient children during the first year of therapy. PubMed PMID: 8772599.
- Low-dose growth hormone-releasing hormone tests: a dose-response study. Human dose-response investigation of GHRH(1-29)NH2. PubMed PMID: 7921207.
- Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency. Review of historical human evidence and clinical research. PubMed PMID: 18031173.
- Growth hormone responses to growth hormone-releasing hormone (1-29)-NH2 and a D-Ala2 analog in normal men. Human endocrine dose-response research. PubMed PMID: 2866496.
Scientific review scope: FDA regulatory history, PubMed-indexed human research, concentration mathematics, and research-language compliance.
Important: Scientific evidence and regulatory status can change. This page should be periodically reviewed as new regulatory documents, clinical studies, or authoritative scientific evidence become available.